Last reviewed · How we verify

NCT06118060

Acupressure on Postoperative Ileus in Patients With Colorectal Cancer Surgery

Status unknown NA Last updated 7 November 2023
What this trial tests

NA trial testing Acupressure in Colorectal Cancer in 104 participants. Status unknown.

Timeline
1 November 2023
Primary endpoint
30 July 2024
30 July 2025

Quick facts

Lead sponsorQilu Hospital of Shandong University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment104
Start date1 November 2023
Primary completion30 July 2024
Estimated completion30 July 2025

Drugs / interventions tested

Conditions studied

Sponsor

Qilu Hospital of Shandong University

Who can join

18 and older, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about acupressure in patients with colorectal cancer surgery. The main questions it aims to answer are: * whether acupressure can improve the motility of vagus nerve in patients after colorectal cancer surgery * whether acupressure can reduce the inflammatory response of the body * whether acupressure can reduce the incidence of gastrointestinal paralysis in patients after colorectal cancer surgery Participants will receive acupressure at ST36 twice daily starting from the first day after surgery and lasting for five days. Researchers will compare usual care group to see if acupressure has those above effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acupressure

Trials testing the same drug.

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

Other Qilu Hospital of Shandong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06118060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing